CMB 1.28% 38.5¢ cambium bio limited

Unlike RGS, MediVet has never been able to publish rigorous...

  1. 163 Posts.
    lightbulb Created with Sketch. 3
    Unlike RGS, MediVet has never been able to publish rigorous evidence of efficacy for its treatments.

    RGS was bashed on national TV for a lack of rigorous evidence of HiQCell efficacy. They still spruik their HiQCell joint registry (from 2014) on there website but have dropped that product-and have published nothing rigorous about efficacy from it.
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.